14(top 5%)
papers
514(top 2%)
citations
11(top 2%)
h-index
13(top 5%)
g-index
14
all documents
536
doc citations
272
citing journals

Top Articles

#TitleJournalYearCitations
1Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent ratsPsychopharmacology2011166
2Metabotropic glutamate receptor 5 in the pathology and treatment of schizophreniaNeuroscience and Biobehavioral Reviews201375
3Probe Sensor Using Nanostructured Multi-Walled Carbon Nanotube Yarn for Selective and Sensitive Detection of DopamineSensors201737
4Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophreniaProgress in Neuro-Psychopharmacology and Biological Psychiatry201136
5Novel implications of Lingo-1 and its signaling partners in schizophreniaTranslational Psychiatry201435
6A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in miceNeuroscience201334
7Sensitive and selective dopamine determination in human serum with inkjet printed Nafion/MWCNT chipsElectrochemistry Communications201334
8Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatmentSchizophrenia Research201334
9Effects of olanzapine on the elevation of macrophage infiltration and pro-inflammatory cytokine expression in female ratsJournal of Psychopharmacology201430
10Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high-fat dietMolecular and Cellular Endocrinology201529
11Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeuticsBMC Psychiatry201421
12Investigation of genetic variants in ubiquitin enzyme genes involved in the modulation of neurodevelopmental processes: a role in schizophrenia susceptibility?Genetical Research20143
13Genetic variants in Nogo receptor signaling pathways may be associated with early life adversity in schizophrenia susceptibilityBBA Clinical20152
14PM426. Effect of a glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, on cognition and body weight during antipsychotic treatmentInternational Journal of Neuropsychopharmacology20160